![](/img/cover-not-exists.png)
A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria
Sardh, E., Balwani, M., Harper, P., Stein, P., Rees, D., Bloomer, J., Bissell, D.M., Parket, C., Phillips, J., Bonkovsky, H., Desnick, R., Al-Tawil, N., Rock, S., Penz, C., Chan, A., Querbes, W., SimoVolume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)30354-4
Date:
April, 2018
File:
PDF, 61 KB
english, 2018